Potassium channel activator with nitrate component
Nicorandil
Brand names: Ikorel
Adult dose
Dose: 5–10mg BD, increase to 20mg BD (max 30mg BD)
Route: PO
Frequency: BD
Clinical pearls
- Adjunct in chronic stable angina when standard therapy insufficient
- MHRA: ulceration is a class effect — counsel patients to report any ulcer; STOP nicorandil and review
Contraindications
- Cardiogenic shock
- Severe hypotension
- LV dysfunction with low filling pressures
- Concurrent PDE-5 inhibitors / riociguat
Side effects
- Headache (common, often improves)
- Flushing
- GI/oral/anal/skin ulceration (MHRA — sometimes severe; STOP if occurs)
- Hypotension
Interactions
- PDE-5 inhibitors (severe hypotension)
- Riociguat
- Antihypertensives
Monitoring
- Mucosal/skin ulceration
Reference: BNF; NICE CG126; MHRA Drug Safety Update; https://bnf.nice.org.uk/drugs/nicorandil/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines